Skip to main content

Deck.blue brings a TweetDeck experience to Bluesky users

With over 3 million users and plans to open up more broadly in the months ahead, Bluesky is still establishing itself as an alternative to Twitter/X. However, that hasn’t stopped the developer community from embracing the project and building tools to meet the needs of those fleeing the now Elon Musk-owned social network, formerly known […] © 2024 TechCrunch. All rights reserved. For personal use only. from TechCrunch https://ift.tt/TBbEAPF
Post a Comment

Nigeria’s Remedial Health gets QED backing in $12M round

Remedial Health, a Nigerian startup digitizing pharmacies and bringing efficiency to the pharmaceutical value chain, has raised $12 million Series A equity-debt funding, to scale operations in the West African country.

Fintech VC firm QED Investors co-led the round, banking on embedded financial opportunities like payments, and lending in the pharmaceutical sector. This is QED’s third investment in Africa after its involvement in the Moniepoint (formerly TeamApt), and Flapkap deals last year. Ventures Platform, also co-led the round, which saw the participation of existing investors like Y Combinator, Tencent and Gaingels.

Pharmacies and hospitals use Remedial Health’s platform to order pharmaceutical products sourced from reliable and trusted manufacturers and verified distributors. This helps to stem erratic prices, and the supply of fake and substandard products that are behind thousands of preventable deaths in Nigeria, and Africa at large. It also ensures a proper handling of the products, which can’t be said of the open drugs market in Nigeria.

QED closes on $925M to back fintech startups globally

A recent report by Nigeria’s National Agency for Food and Drug Administration and Control estimates that about 15% of the medicine sold in the country is fake or sub-standard. Besides, it is estimated by the United Nations Office on Drugs and Crime, that half a million people die in sub-Saharan Africa owing to substandard or counterfeit medicine.

Remedial Health gets $4 million debt funding to scale inventory financing

Founded by Samuel Okwuada (CEO), and Victor Benjamin (COO) in 2021, Remedial Health plans to use the new funding to deepen its operations in Nigeria. The funding includes $4 million debt to help it scale inventory financing.

Okwuada told TechCrunch that priority at the moment remains on increasing penetration in 34 states by getting more pharmacies and hospitals signed up, especially in rural areas, where demand is growing.

“We are seeing more growth in rural areas, because they are difficult to reach, and are far from major open drug markets in Nigeria,” said Okwuada, adding that the startup currently has a “considerable market share” in at least half of the 34 of 36 states it operates in within Nigeria.

The YC-alumni currently serves over 5,000 pharmacies and hospitals, having grown its client count by 3X since November last year. It sources the over 8,000 products it sells from 300 manufacturers, among them GSK, Pfizer and AstraZeneca.

Its inventory financing, which enables its clients to restock without upfront payment, has helped grow its client count, and revenues by 7X over the last 10 months too.

“We are a B2B business and we are able to provide inventory to these pharmacies without requesting cash up-front, or at the point of delivery… We’ve seen them grow their businesses, open additional branches because they are able to get credit,” said Okwuada.

Remedial’s platform enables its customers to manage their operations including inventory management (through an app too), accounting, and financial reporting. It also provides real-time market intelligence that informs manufacturers on production and distribution.

Okwuada said its customers receive orders within 24 hours. The startup has a network of distribution hubs, spread across the regions it serves, and does last-mile delivery in-house or through partners. Other startups bringing efficiency in the pharmaceutical value chain include MyDawa, and DrugStoc.

Commenting on the investment, QED Investors partner, and head of Africa, Gbenga Ajayi said in a statement: “The success that Remedial Health has enjoyed to date is an indication of the market gap that exists, and their value in providing effective holistic services to thousands of pharmacies across Nigeria.”

“QED is particularly excited about the embedded financial services opportunities within the vertical — the ability to provide payments, embedded lending and other fintech solutions to this underserved but very crucial sector.”

Nigeria’s YC-backed Remedial Health raises $4.4M seed funding

Kenya’s MyDawa aims to be an all-in-one health platform backed by $20 million funding



from TechCrunch https://ift.tt/oqlKt5g
Labels:

Comments

Post a Comment

Popular posts from this blog

Nimbus launches tiny EV prototype that’s like a motorbike with a roof

As shared e-scooter companies have infiltrated cities and e-bike sales have soared, micromobility has been offered up as a panacea to save us all from the ill humors and packed streets caused by gas-guzzling cars. However, one of the major roadblocks in front of well-intentioned city dwellers who’d love to trade in their cumbersome and environmentally unfriendly vehicles for an e-bike or scooter remains: What happens when it rains? Nimbus, a California-based electric vehicle startup, wants to solve that problem with a simple solution: Put a roof on it. The company recently came out of stealth with a prototype for its Nimbus One, a tiny, three-wheeled EV that “combines the convenience and cost of a motorbike with the safety and comfort of a car.” The Nimbus One. Image Credits: Nimbus The thin, pod-like vehicle is only about 2.75 feet wide and 7.5 feet long, which Nimbus says makes it three to five times smaller than a compact car — the better to park and navigate busy urban stree...
Post a Comment
Read more

Coinbase Q2 earnings exceed estimates, signaling potential market recovery

Coinbase reported its second quarter earnings Thursday afternoon after the bell, beating market estimates. During Q2, the second largest crypto exchange by trading volume generated total revenues of $707.9 million, down from $772.5 in the previous quarter and $808.3 million in the year-ago quarter. It also had a $97 million net loss and generated a positive adjusted EBITDA of $194 million during the quarter. It was a mixed bag of estimates from analysts prior to the earnings report. Some expected lower results, while others were optimistic . But now crypto bulls and company shareholders alike can breathe a sigh of relief. “One year ago in Q2 2022, we started reducing our expense base to operate more efficiently. One year later, we’re proud to say that our quarterly recurring operating expenses have dropped nearly 50% Y/Y,” the company said in its Q2 2023 shareholder letter . In after-hours trading, shares of Coinbase rose 7% to about $96.70 after its earnings were posted, but re...
Post a Comment
Read more

Silicon Valley goes to war

At Andreessen Horowitz’s recent American Dynamism summit, Hadrian founder and CEO Chris Power painted a picture of the country in peril. “I’m here to talk to you about an existential risk to the future of the Republic and how Hadrian is trying to solve it,” he began . His words – a mix of rationalism and Marcus Aurelius – were not out of place at the event, which brought together a blend of investors, founders, policymakers and other Washington officials to discuss issues facing the country. A notable number of talks were related to defense and national security, in line with the American Dynamism team’s investment portfolio, which includes bets on defense tech startups like Hadrian, Anduril and Shield AI. Just a few years ago, many investors thought that cutting a check for a defense-first startup was a proposition that simply didn’t make sense. The tides have clearly shifted: a16z is one of many firms that’s taken a stronger interest in defense and national security. PitchBook data...
Post a Comment
Read more